Home > Offer to Sell > Intermediates > Pharmaceutical intermediates > Lapatinib

Lapatinib

Inquiry
  Post Date: Oct 16,2019
  Expiry Date: Apr 13,2020
  Detailed Description: Cas No. :231277-92-2 lapatinib;n-(3-chloro-4-((3-fluorophenyl)methoxy)phenyl)-6-(5-((2-methylsulfonylethylamino)methyl)-2-furyl)quinazolin-4-amine

  CAS Registry Number:

231277-92-2

  Synonyms: ;4-Quinazolinamine, N-[3-chloro-4-[(3-fluorophenyl)methoxy]phenyl]-6-[5-[[[2-(methylsulfonyl)ethyl]amino]methyl]-2-furanyl]-;N-[3-Chloro-4-[(3-fluorophenyl)methoxy]phenyl]-6-[5-[(2-methylsulfonylethylamino)methyl]-2-furyl]quinazolin-4-amine;N-[3-chloro-4-[(3-fluorophenyl)methoxy]phenyl]-6-[5-[[[2-(methylsulfonyl)ethyl]amino]methyl]-2-furanyl]-4-Quinazolinamine;N-{3-chloro-4-[(3-fluorobenzyl)oxy]phenyl}-6-[5-({[2-(methylsulfonyl)ethyl]amino}methyl)furan-2-yl]quinazolin-4-amine;Lapatinib base;
  Molecular Formula: C29H26ClFN4O4S
  Molecular Weight: 581.0575
  Molecular Structure: 231277-92-2 Lapatinib

  Company: Nanjing CHICO pharmaceutical Co.,Ltd     [ China ]          
  Contact: Mr WU
  Tel: +86-25-84351604
  Fax: +86-25-52261140
  Email: sales@chicopharm.com
Disclaimer statement:The information and data included above have been realized by the enterprises and compiled by the staff, and are subject to change without notice to you. The Chemnet makes no warranties or representations whatsoever regarding the facticity, accuracy and validity of such information and data. In order to ensure your interest, we suggest you chose the products posted by our gold suppliers or VIP members.